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The genetic basis of psoriasis has long been recognized, including the knowledge 
that family members of patients with psoriasis are at greater risk of developing the 
disease (Henselers and Christophers, 1995). Several lines of evidence suggest that 
genes regulating IL-12 and IL-23 may be important in its pathogenesis. Part of the 
rationale stems from observations indicating that patients with psoriasis and those 
with Crohn’s disease share common features: patients with Crohn’s disease are five 
times more likely than the general population to have psoriasis, and both diseases 
respond to anti–tumor necrosis factor-α therapy (Lee et al., 1990). A recent genome-
wide association scan identified a highly significant association between Crohn’s 
disease and a single-nucleotide polymorphism (SNP) in the coding region of the IL23R gene (Duerr et al., 2006), 
suggesting that this polymorphism might be present in patients with psoriasis. Additional studies from several diverse 
ethnic populations throughout the world have determined that psoriasis is associated with SNPs in IL-12 and IL-23 or 
their receptors (Capon et al., 2007; Cargill et al., 2007; Chang et al., 2007; Tsunemi et al., 2002).
On the basis of the above information, Nair et al. (2008) studied four candidate SNPs in a large (more than 4,000 
persons) cohort of white North American and German subjects with psoriasis and in controls. Two of the SNPs were 
the IL12B haplotype rs3212227 and rs6887695; the other two were IL23R haplotype rs7530511 and rs11209026. Nair et 
al. found that both IL12B markers had a highly significant association with psoriasis (odds ratio (OR) 1.62 and 1.49 for 
rs3212227 and rs6887695, respectively). The IL23R SNPs also demonstrated significant associations in the cases and 
controls (OR 1.22 and 1.40 for rs7530511 and rs11209026, respectively). These SNPs were not found to have interactions 
with a known genetic risk factor, HLA-Cw6.
Through the following questions, we examine this paper in greater detail. For brief answers, please refer to http://
network.nature.com/group/jidclub.
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QUESTIONS
1. What is a single-nucleotide polymorphism (SNP)?
2. What data support an association between Crohn’s disease and psoriasis?
3. Why are IL12B and IL23R candidates for study?
4. How was the study performed?
5. What were the major findings of this study?
6. What may be the clinical implications of this study, and how may they change the way we think about the genetics of psoriasis?
7. What future studies might extend these findings? 
